Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) was $15.28 for the day, down -1.86% from the previous closing price of $15.57. In other words, the price has decreased by -$1.86 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
Our analysis of SNDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.99 and its Current Ratio is at 6.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $37.
Scotiabank Downgraded its Sector Outperform to Sector Perform on January 31, 2024, whereas the target price for the stock was revised from $36 to $23.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 10 ’25 when Goldan Keith A. sold 3,777 shares for $15.50 per share. The transaction valued at 58,559 led to the insider holds 90,746 shares of the business.
Metzger Michael A sold 13,288 shares of SNDX for $206,017 on Feb 10 ’25. The Chief Executive Officer now owns 300,121 shares after completing the transaction at $15.50 per share. On Feb 10 ’25, another insider, Gallagher Neil, who serves as the President, Head of R&D of the company, sold 4,618 shares for $15.50 each. As a result, the insider received 71,597 and left with 85,095 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 81.52 while its Price-to-Book (P/B) ratio in mrq is 3.57.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $12.06. The 50-Day Moving Average of the stock is 8.17%, while the 200-Day Moving Average is calculated to be -16.23%.
Shares Statistics:
A total of 85.57M shares are outstanding, with a floating share count of 83.50M. Insiders hold about 2.18% of the company’s shares, while institutions hold 117.67% stake in the company.
